Roles of Histone H2B, H3 and H4 Variants in Cancer Development and Prognosis
International Journal of Molecular Sciences · 07.09.2024 · 25 (17) · 9699
DOI: 10.3390/ijms25179699 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 07.09.2024. Verfasst von Po Man Lai und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China. Hauptthemen laut MEDLINE: Histones, Genetic Variation, Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 213 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Foundation China, Research Grants Council Hong Kong, National Science Foundation of China.
Abstract (Originalsprache)
Histone variants are the paralogs of core histones (H2A, H2B, H3 and H4). They are stably expressed throughout the cell cycle in a replication-independent fashion and are capable of replacing canonical counterparts under different fundamental biological processes. Variants have been shown to take part in multiple processes, including DNA damage repair, transcriptional regulation and X chromosome inactivation, with some of them even specializing in lineage-specific roles like spermatogenesis. Several reports have recently identified some unprecedented variants from different histone families and exploited their prognostic value in distinct types of cancer. Among the four classes of canonical histones, the H2A family has the greatest number of variants known to date, followed by H2B, H3 and H4. In our prior review, we focused on summarizing all 19 mammalian histone H2A variants. Here in this review, we aim to complete the full summary of the roles of mammalian histone variants from the remaining histone H2B, H3, and H4 families, along with an overview of their roles in cancer biology and their prognostic value in a clinical context.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biomedical Sciences, City University of Hong Kong, Hong Kong SAR, China.
ORCID-Profile: Po Man Lai, Kui Ming Chan
Förderung
- National Science Foundation China
- Research Grants Council Hong Kong
- National Science Foundation of China
- Research Grants Council of Hong Kong
Zitieren
APA
Lai, P. M., Gong, X., & Chan, K. M. (2024). Roles of Histone H2B, H3 and H4 Variants in Cancer Development and Prognosis. International Journal of Molecular Sciences, 25(17), 9699. https://doi.org/10.3390/ijms25179699
Vancouver
Lai PM, Gong X, Chan KM. Roles of Histone H2B, H3 and H4 Variants in Cancer Development and Prognosis. International Journal of Molecular Sciences. 2024;25(17):9699. doi:10.3390/ijms25179699
BibTeX
@article{Lai2024,
author = {Lai, Po Man and Gong, Xiaoxiang and Chan, Kui Ming},
title = {Roles of Histone H2B, H3 and H4 Variants in Cancer Development and Prognosis},
journal = {International Journal of Molecular Sciences},
year = {2024},
volume = {25},
number = {17},
pages = {9699},
doi = {10.3390/ijms25179699}
}
EUVIMED